Fisher R F, Yanofsky C
J Biol Chem. 1983 Jul 10;258(13):8146-50.
RNA polymerase was purified from rifampicin-resistant mutants of Escherichia coli which exhibit altered transcription termination at the trp operon attenuator in vivo. These mutant polymerases were used to investigate transcription pausing at the trp leader pause site and transcription termination at the trp attenuator. The mutant polymerases examined in vitro mimic their in vivo termination responses; i.e. RNA polymerase isolated from a mutant which displays high transcriptional read-through of the trp operon in vivo allows greater transcriptional read-through in vitro, while RNA polymerase prepared from a mutant which has reduced read-through in vivo exhibits greater termination of transcription in vitro. The observed differences are not due to the presence of--or response to--alternate secondary structures in the trp leader transcript since deletion of the DNA segment corresponding to some of these alternate structures does not affect termination efficiency. The mutant polymerases also have comparable effects on the kinetics of transcription pausing at the trp leader pause site; the termination-deficient polymerase exhibits diminished pausing while the termination-proficient polymerase displays enhanced pausing. We suggest that this correlation reflects polymerase recognition of similar features of RNA secondary structures in the pause and termination events. In addition, since single mutational changes in RNA polymerase affect two activities, pausing and termination, it is likely that a single site or region of the polymerase is involved in both events.
RNA聚合酶是从大肠杆菌的利福平抗性突变体中纯化得到的,这些突变体在体内的色氨酸操纵子衰减子处表现出转录终止的改变。这些突变型聚合酶被用于研究色氨酸前导序列暂停位点处的转录暂停以及色氨酸衰减子处的转录终止。体外检测的突变型聚合酶模拟了它们在体内的终止反应;即,从在体内表现出色氨酸操纵子高转录通读的突变体中分离得到的RNA聚合酶在体外允许更大程度的转录通读,而从在体内通读减少的突变体中制备的RNA聚合酶在体外表现出更大程度的转录终止。观察到的差异并非由于色氨酸前导转录本中存在交替二级结构或对其的反应,因为删除与其中一些交替结构相对应的DNA片段不会影响终止效率。突变型聚合酶对色氨酸前导序列暂停位点处的转录暂停动力学也有类似影响;终止缺陷型聚合酶表现出暂停减少,而终止 proficient型聚合酶表现出暂停增强。我们认为这种相关性反映了聚合酶在暂停和终止事件中对RNA二级结构相似特征的识别。此外,由于RNA聚合酶中的单个突变变化会影响暂停和终止这两种活性,很可能聚合酶的单个位点或区域参与了这两个事件。